These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 30253677)
1. Fewer women aged 35 and older choose serum screening for Down's syndrome: Impact and implications. Lambert-Messerlian G; Palomaki GE J Med Screen; 2019 Jun; 26(2):59-66. PubMed ID: 30253677 [TBL] [Abstract][Full Text] [Related]
2. Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free betahCG and PAPP-A. Spencer K BJOG; 2001 Oct; 108(10):1043-6. PubMed ID: 11702835 [TBL] [Abstract][Full Text] [Related]
3. Antenatal screening for Down's syndrome. Wald NJ; Kennard A; Hackshaw A; McGuire A J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915 [TBL] [Abstract][Full Text] [Related]
4. Antenatal screening for Down's syndrome with the quadruple test. Wald NJ; Huttly WJ; Hackshaw AK Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052 [TBL] [Abstract][Full Text] [Related]
6. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome. Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976 [TBL] [Abstract][Full Text] [Related]
7. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. Wald NJ; Watt HC; Hackshaw AK N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601 [TBL] [Abstract][Full Text] [Related]
9. The effect of differences in the distribution of maternal age in England and Wales on the performance of prenatal screening for Down's syndrome. Huang T; Watt HC; Wald NJ Prenat Diagn; 1997 Jul; 17(7):615-21. PubMed ID: 9249861 [TBL] [Abstract][Full Text] [Related]
10. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment. Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355 [TBL] [Abstract][Full Text] [Related]
11. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869 [TBL] [Abstract][Full Text] [Related]
12. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852 [TBL] [Abstract][Full Text] [Related]
13. Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin. Spencer K; Carpenter P BMJ; 1993 Sep; 307(6907):764-9. PubMed ID: 7693095 [TBL] [Abstract][Full Text] [Related]